Dr. Praveen Kumar Neeli is a molecular oncology researcher specializing in cancer immunotherapy, DNA vaccines, and CAR-T cell therapies. His work focuses on targeting stress signaling pathways to improve treatment outcomes in metastatic breast cancer and hematological malignancies. He has contributed to innovative vaccine platforms, immune checkpoint therapies, and tumor-targeting strategies, with multiple high-impact publications and patents. His research integrates molecular biology, immunology, and bioinformatics to advance precision medicine. Dr. Neeli has extensive experience in translational research, contributing to novel therapeutic approaches for cancer and infectious diseases while mentoring young scientists and engaging in scientific publishing.
Citation Metrics (Scopus)
Citations
Documents
h-index
View Scopus Profile View ORCID Profile View Google Scholar Profile
Featured Publications